The profile is broadly comparable to, though not identical to, the side effect profiles of semaglutide and tirzepatide
The result should still be interpreted alongside tolerability: nearly four in five participants receiving CagriSema reported gastrointestinal adverse events, although most were transient and mild to moderate
The anecdata seem to indicate that the mode of delivery, that is whether or not systemic or local, doesn't seem to matter that much
In addition, there is a likely analogy (see for review i.e., (Seiwerth et al., 2018)) with the attenuated fibrosis and scar formation in other tissues (i.e., the skin, muscle, tendon, and ligament) (Mikus et al., 2001
Why is peptide purity so important